Insulet Corporation number of employees

Insulet Corporation reported 5,400 employees at December 31, 2025 in its latest annual report, up 1,500 (38.5%) on the year before. That compares with 2,300 at December 31, 2021. Revenue per employee was $501,500.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	5,400	+1,500 (38.5%)	$501,500	10-K, filed February 18, 2026
December 31, 2024	3,900	+900 (30.0%)	$531,179	10-K, filed February 21, 2025
December 31, 2023	3,000	+400 (15.4%)	$565,700	10-K, filed February 23, 2024
December 31, 2022	2,600	+300 (13.0%)	$502,038	10-K, filed February 24, 2023
December 31, 2021	2,300	—	$477,739	10-K, filed February 24, 2022

What the annual reports say

As of December 31, 2025, we had approximately 5,400 full-time employees, representing a 38% increase over the prior year. 2025 annual report
As of December 31, 2024, we had approximately 3,900 full-time employees, representing a 29% increase over the prior year. 2024 annual report
As of December 31, 2023, we had approximately 3,000 full-time employees, representing an 18% increase over the prior year. 2023 annual report
As of December 31, 2022, we had approximately 2,600 full-time employees, representing a 13% increase over the prior year. 2022 annual report
As of December 31, 2021, we had approximately 2,300 full-time employees, representing a 21% increase over the prior year. 2021 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: GMED vs PODD PODD vs RVTY PODD vs QDEL

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Insulet Corporation's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Insulet Corporation.